I agree that this site is using cookies. You can find further informations here.
X
Domingo‐Domenech, E.
58  results:
Search for persons X
?
1

Baseline‐PET derived metrics are the most relevant factors ..:

Zaucha, J. M. ; Picardi, M. ; Kurlapski, M....
Hematological Oncology.  41 (2023)  S2 - p. 350-351 , 2023
Link: https://doi.org/10.1002/..
 
?
2

Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazin..:

Abramson, J. S. ; Straus, D. ; Bartlett, N....
Hematological Oncology.  41 (2023)  S2 - p. 353-355 , 2023
Link: https://doi.org/10.1002/..
 
?
3

THE LOW‐RISK EARLY‐STAGE HODGKIN LYMPHOMA PATIENTS WITH INA..:

Filonenko, K. ; Domingo‐Domenech, E. ; Gotti, M....
Hematological Oncology.  41 (2023)  S2 - p. 674-675 , 2023
Link: https://doi.org/10.1002/..
 
?
4

INVESTIGATING SAFETY AND PRELIMINARY EFFICACY OF AFM13 PLUS..:

Ansell, S.M. ; Bartlett, N.L. ; Chen, R.W....
Hematological Oncology.  37 (2019)  S2 - p. 177-178 , 2019
Link: https://doi.org/10.1002/..
 
?
5

TIPIFARNIB IN RELAPSED OR REFRACTORY ANGIOIMMUNOBLASTIC T‐C..:

Witzig, T. ; Sokol, L. ; Kim, W....
Hematological Oncology.  37 (2019)  S2 - p. 64-65 , 2019
Link: https://doi.org/10.1002/..
 
?
6

NIVOLUMAB PLUS DOXORUBICIN, VINBLASTINE AND DACARBAZINE FOR..:

Ansell, S. ; Ramchandren, R. ; Domingo‐Domènech, E....
Hematological Oncology.  37 (2019)  S2 - p. 146-147 , 2019
Link: https://doi.org/10.1002/..
 
?
7

LONG‐TERM RESULTS OF THE MULTICENTER PHASE II TRIAL WITH BE..:

Salar, A. ; Domingo‐Domenech, E. ; Panizo, C....
Hematological Oncology.  35 (2017)  S2 - p. 147-148 , 2017
Link: https://doi.org/10.1002/..
 
?
8

All‐trans retinoic acid‐induced myositis in a case of acute..:

Oliveira, A. C. ; Domingo‐Domenech, E. ; Arnan, M....
International Journal of Laboratory Hematology.  30 (2008)  3 - p. 254-255 , 2008
Link: https://doi.org/10.1111/..
 
?
9

Outcomes of allogeneic hematopoietic cell transplantation a..:

Peña, M. ; Montané, C. ; Paviglianiti, A....
Bone Marrow Transplantation.  58 (2023)  11 - p. 1282-1285 , 2023
Link: https://doi.org/10.1038/..
 
?
10

P14.02.B LONGITUDINAL COMPARATIVE ANALYSIS OF BLOOD NEUROFI..:

Velasco, R ; Marco, C ; Ferrer, G...
Neuro-Oncology.  25 (2023)  Supplement_2 - p. ii105-ii105 , 2023
Link: https://doi.org/10.1093/..
 
?
11

P1260: UNRAVELING THE GENETICS OF TRANSFORMED SPLENIC MARGI..:

Grau, M. ; López, C. ; Navarro, A....
HemaSphere.  6 (2022)  - p. 1145-1146 , 2022
Link: https://doi.org/10.1097/..
 
?
12

PB2125: LYMPHOMATOID PAPULOSIS-LIKE (LYP-LIKE) AFTER BRENTU..:

Lopez Pereira, P. ; Servitje, O. ; Climent, F....
HemaSphere.  6 (2022)  - p. 1996-1997 , 2022
Link: https://doi.org/10.1097/..
 
?
13

P1083: BRENTUXIMAB VEDOTIN, ETOPOSIDE, SOLUMEDROL, HIGH DOS..:

Garcia-Sanz, R. ; Martínez, C. ; De la Cruz, F....
HemaSphere.  6 (2022)  - p. 973-974 , 2022
Link: https://doi.org/10.1097/..
 
?
14

The ECHELON-2 Trial: 5-year results of a randomized, phase ..:

Horwitz, S. ; O'Connor, O.A. ; Pro, B....
Annals of Oncology.  33 (2022)  3 - p. 288-298 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Allogeneic hematopoietic stem cell transplantation for adva..:

Domingo-Domenech, E. ; Duarte, R. F. ; Boumedil, A....
Bone Marrow Transplantation.  56 (2021)  6 - p. 1391-1401 , 2021
Link: https://doi.org/10.1038/..
 
1-15